RAY1216 tablets

· Guangdong Raynovent Biotech Co., Ltd

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for RAY1216 tablets, covering 2023-05-24 to 2023-05-24. Get the full timeline:

Most recent: Clinical Trial Update: Study of RAY1216 Tablets Compared With Placebo in Patients With Mild to Moderate COVID-19 [Phase 3]